0
Signin
countryflagUS

18889881171

MSFT 425.025 -0.9035% AAPL 220.43 0.8648% NVDA 115.85 1.4004% GOOGL 172.44 -0.1101% GOOG 174.27 -0.0573% AMZN 182.99 1.1945% META 460.09 -0.2558% AVGO 152.64 0.859% TSLA 224.8499 4.102% TSM 161.61 1.1327% LLY 823.56 -4.2238% V 257.56 1.3338% JPM 209.535 0.453% UNH 562.83 0.5502% NVO 129.31 -1.7401% WMT 70.206 -0.5581% LVMUY 143.15 0.9022% XOM 116.85 1.5999% LVMHF 714.04 0.4982% MA 436.96 1.0429%

Bioelectronics Corp

Healthcare US BIEL

0.0002USD
-(-%)

Last update at 2024-07-24T13:30:00Z

Day Range

0.00010.0002
LowHigh

52 Week Range

0.00020.0007
LowHigh

Fundamentals

  • Previous Close 0.0002
  • Market Cap7.41M
  • Volume7140979
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.36445M
  • Revenue TTM1.61M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.80M
  • Diluted EPS TTM-

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Type yearly yearly yearly yearly yearly
Date 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Income before tax - - - -2.98834M -2.11879M
Minority interest - - - 0.00000M 0.00000M
Net income - - - -2.98834M -2.11879M
Selling general administrative - - - 1.80M 1.88M
Selling and marketing expenses - - - - -
Gross profit - - - 0.36M 1.00M
Reconciled depreciation - - - - -
Ebit -0.13713M -1.03278M -1.30605M -2.01002M -1.29671M
Ebitda - - - - -
Depreciation and amortization - - - - -
Non operating income net other - - - 0.00000M 0.00000M
Operating income - - - -2.01002M -1.29671M
Other operating expenses - - - 0.00000M 0.00000M
Interest expense 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - 0.00000M 0.00000M
Non recurring - - - 0.00000M 0.00000M
Other items - - - 0.00000M 0.00000M
Income tax expense - - - 0.00000M 0.00000M
Total revenue - - - 1.05M 1.76M
Total operating expenses - - - 3.06M 3.06M
Cost of revenue - - - 0.69M 0.77M
Total other income expense net - - - -0.97833M -0.82209M
Discontinued operations - - - 0.00000M 0.00000M
Net income from continuing ops - - - -2.98834M -2.11879M
Net income applicable to common shares -0.28982M -1.15972M -2.32528M -2.98834M -2.11879M
Preferred stock and other adjustments - - - 0.00000M 0.00000M
Breakdown 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Type yearly yearly yearly yearly yearly
Date 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Total assets - - - 0.47M 0.50M
Intangible assets - - - 0.00000M 0.00000M
Earning assets - - - - -
Other current assets - - 0.01M 0.02M 0.03M
Total liab - - - 13.49M 11.19M
Total stockholder equity - - - -13.02265M -10.68441M
Deferred long term liab - - - 0.00000M 0.00000M
Other current liab 0.58M 1.00M 0.30M 0.54M 0.03M
Common stock 24.38M 24.13M 22.92M 20.71M 18.99M
Capital stock - - - - -
Retained earnings -38.30648M -38.24635M -37.08663M -34.76135M -31.77301M
Other liab - - - 0.00000M 0.00000M
Good will - - - 0.00000M 0.00000M
Other assets - - - 0.00000M 0.00000M
Cash - - - 0.09M 0.00889M
Cash and equivalents - - - - -
Total current liabilities 5.93M 8.84M 9.28M 8.80M 5.59M
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - 0.00000M 0.00000M
Short long term debt - - - 7.31M 4.62M
Short long term debt total - - - - -
Other stockholder equity -1.18986M -1.01052M -0.40554M 0.00000M 0.00000M
Property plant equipment - - - 0.00083M 0.00304M
Total current assets 0.08M 0.43M 0.34M 0.47M 0.50M
Long term investments - - - 0.00000M 0.00000M
Net tangible assets -15.11750M -15.12209M -14.57465M -13.02265M -10.68441M
Short term investments - - - 0.00000M 0.00000M
Net receivables 0.06M 0.16M 0.19M 0.06M 0.02M
Long term debt - - - 4.69M 5.59M
Inventory 0.03M 0.15M 0.10M 0.29M 0.44M
Accounts payable 0.65M 0.73M 1.82M 0.96M 0.95M
Total permanent equity - - - 0.00000M 0.00000M
Noncontrolling interest in consolidated entity - - - 0.00000M 0.00000M
Temporary equity redeemable noncontrolling interests - - - 0.00000M 0.00000M
Accumulated other comprehensive income - - - 0.00000M 0.00000M
Additional paid in capital - - - 0.00000M 0.00000M
Common stock total equity - - - 0.00000M 0.00000M
Preferred stock total equity - - - 0.00000M 0.00000M
Retained earnings total equity - - - 0.00000M 0.00000M
Treasury stock - - - 0.00000M 0.00000M
Accumulated amortization - - - 0.00000M 0.00000M
Non currrent assets other - - - 0.00000M 0.00000M
Deferred long term asset charges - - - 0.00000M 0.00000M
Non current assets total - - - 0.00000M 0.00000M
Capital lease obligations - - - 0.00000M 0.00000M
Long term debt total - - - 0.00000M 0.00000M
Breakdown 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Type yearly yearly yearly yearly yearly
Date 2021-12-31 2020-12-31 2019-12-31 2018-12-31 2017-12-31
Investments - - - 0.00000M 0.00000M
Change to liabilities -0.51107M 0.25M 0.63M 0.52M 0.27M
Total cashflows from investing activities - - - 0.00000M 0.00000M
Net borrowings 0.32M 0.72M 0.67M 1.48M 0.88M
Total cash from financing activities 0.21M 0.59M 0.67M 1.44M 0.87M
Change to operating activities - 0.01M 0.00515M 0.00515M -0.03500M
Net income -0.28982M -1.15972M -2.32528M -2.98834M -2.11879M
Change in cash -0.10869M 0.06M -0.04671M 0.08M 0.00312M
Begin period cash flow - - - - -
End period cash flow - - - - -
Total cash from operating activities -0.32030M -0.52804M -0.71568M -1.35241M -0.86891M
Issuance of capital stock - - - - -
Depreciation - - 0.00083M 0.00221M 0.00221M
Other cashflows from investing activities - - - 0.00000M 0.00000M
Dividends paid - - - 0.00000M 0.00000M
Change to inventory 0.13M -0.05246M 0.20M 0.15M 0.14M
Change to account receivables 0.11M 0.00950M -0.18000M -0.12180M 0.07M
Sale purchase of stock - - - 0.00000M 0.00000M
Other cashflows from financing activities -0.11247M -0.13169M -0.13169M -0.04414M -0.01141M
Change to netincome 0.25M 0.42M 0.96M 1.09M 0.81M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change receivables - - - 0.00000M 0.00000M
Cash flows other operating - - - 0.00000M 0.00000M
Exchange rate changes - - - 0.00000M 0.00000M
Cash and cash equivalents changes - - - 0.00000M 0.00000M
Change in working capital - - - - -
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow - - - - -

Peer Comparison

Sector: Healthcare Industry: Medical Devices

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x)
BIEL
Bioelectronics Corp		 - -% 0.0002 - - 5.37 -
ABT
Abbott Laboratories		 -0.469 0.44% 106.79 37.15 23.15 4.67 4.97 4.88 19.38
SYK
Stryker Corporation		 -4.36 1.28% 336.06 44.07 24.94 5.51 6.12 6.05 25.73
MDT
Medtronic PLC		 0.30 0.38% 80.27 26.60 15.87 3.35 2.08 3.90 14.12
BSX
Boston Scientific Corp		 -1.58 2.03% 76.18 68.17 24.57 5.85 4.26 6.46 26.80

Reports Covered

Stock Research & News

View All

Profile

BioElectronics Corporation, an electroceutical company, engages in the development and sale of wearable, neuromodulation devices to mitigate neurological diseases and enhance quality of life worldwide. Its products include ActiPatch, a musculoskeletal pain therapy; Allay, a menstrual pain therapy; and Smart Insole, a heel pain therapy. The company also offers RecoveryRx, a medical device that provides pain management therapy for medical professionals; and HealFast, a drug-free therapy for horses, cats, and dogs that reduces swelling and pain, as well as heals muscle and tendon injuries, sores, and incisions. It sells its products to wholesale distributors, hospitals and clinics, and consumers. The company was incorporated in 2000 and is headquartered in Frederick, Maryland.

Bioelectronics Corp

4539 Metropolitan Court, Frederick, MD, United States, 21704

Key Executives

Name Title Year Born
Mr. Andrew J. Whelan Founder 1942
Ms. Kelly A. Whelan CEO, Pres, Treasurer & Exec. Director NA
Mr. Keith E. Nalepka VP of Sales & Marketing and Exec. Director 1974
John R. Martinez Sec. & VP of Engineering NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.